Last reviewed · How we verify
NCT06312280: OBIASITY
Evaluation of Body Composition in Pediatric Patients With Overweight or Obesity
trial testing Mediterranean diet in Pediatric Obesity in 70 participants. Status unknown.
1 May 2024
Quick facts
| Lead sponsor | Azienda Ospedaliero Universitaria Maggiore della Carita |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 70 |
| Start date | 1 April 2024 |
| Primary completion | 1 May 2024 |
| Estimated completion | 30 November 2024 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- Mediterranean diet
Conditions studied
- Pediatric Obesity — all drugs for Pediatric Obesity →
Sponsor
Azienda Ospedaliero Universitaria Maggiore della Carita — full company profile →
Who can join
Adults 6 to 17, any sex, with Pediatric Obesity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In recent decades, the prevalence of obesity and overweight has dramatically increased globally, representing a serious problem for society and for the health system of many countries, estimating an impact of 2-8% on global health spending. Obesity and overweight represent a problem not only for adults but also for children and adolescents: the latest data from the WHO estimate that about 340 million children and adolescents between 5 and 19 years are overweight or obese, data that increase drastically since 1975 from 4% of boys to 18% in 2016. (World Health Organization (WHO). The reduction and prevention of overweight and obesity in childhood is one of the main missions of public health at the global level, both for short-term and long-term implications. Recently, the importance of bioprothesiometric analysis (BIA) in the clinical routine has been evaluated, as it allows an estimation of body composition that would not otherwise be provided by the growth curves and the calculation of the Body Mass Index (BMI). In this study the investigators want to evaluate, in addition to the classic clinical parameters, the body composition of patients evaluated by means of an impedance balance (named TANITA MC780 MA P). With this study the investigators aim to investigate possible clinical and body composition changes in children and adolescents suffering from overweight and obesity with the ultimate aim of reducing cardio-metabolic risk factors related to it. The objective of the study is the assessment of body composition, as an indicator of accuracy of lean mass, but especially of fat mass, of pediatric patients who are overweight and obesity in order to carry out a more complete evaluation of the clinical-metabolic condition for the prevention of cardiovascular risk. The secondary objective is to assess the dietary compliance of the patients being studied and the possible correlation with the body composition.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06312280
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Mediterranean diet
Trials testing the same drug.
- NCT07385716 — Evaluation of the Effect of Time-Restricted Feeding and Mediterranean Diet Model in Women With Polycystic Ovary Syndrome · NA · recruiting
- NCT07017127 — Remission of Type 2 Diabetes With Lifestyle Intervention · NA · recruiting
- NCT07055620 — Effects of Different Dietary Models on Eating Behavior and Obesity Management in Overweight and Obese Individuals · NA · completed
- NCT06774079 — Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) and Diet in Inflammatory Bowel Disease (IBD) Patients · Phase 4 · recruiting
- NCT06765369 — How the Mediterranean Diet Affects You: Predicting Responses Based on Your Microbiome · NA · not yet recruiting
Other recruiting trials for Pediatric Obesity
Currently open trials in the same condition.
- NCT06565455 — Growing Healthy Children and Families in Rural Arkansas · NA · recruiting
- NCT07342855 — Comparing Outcomes Among Children With Obesity in a Community Healthy Lifestyle Program · NA · recruiting
- NCT07095166 — Monitoring Eating Across Locations (MEAL) - Timing, Intake, and Mealtime Evaluation (TIME) · NA · recruiting
- NCT07229508 — Developmental Trajectories of Reinforcer Pathology and Childhood Obesity · recruiting
- NCT06572345 — Low EnerGy DiEt iN Adolescents With Obesity and Type 2 Diabetes: The LEGEND Study · NA · recruiting
Other Azienda Ospedaliero Universitaria Maggiore della Carita trials
Trials by the same sponsor.
- NCT06542926 — NON-COlorectal Liver METastases Undergoing Liver Resection · not yet recruiting
- NCT05298891 — Hypoproteic Diet in Acromegaly · NA · unknown
- NCT06438900 — Investigating the Link Between Advanced Glycation End Products (AGEs) and Muscle Wasting in Sarcobesity · recruiting
- NCT06370507 — Monitoring of Lung Ventilation Through Electrical Impedance Tomography During Pediatric Surgery · not yet recruiting
- NCT06365567 — Dietary Fructose: a Metabolic Switch in Pediatric Obesity-related Disease. · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06312280 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Azienda Ospedaliero Universitaria Maggiore della Carita
- Last refreshed: 19 March 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06312280.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing